glp 1 economist The appetite for weight-loss drugs, known as GLP-1 agonists, has been insatiable since they hit the market a decade ago. As pharmaceutical firms elbow each other for a slice of the pie GLP-1 Drugs Drop More Than

Studies were divided in cognitive disorders, substance-use disorders, psychotic disorders, mood and anxiety disorders, and eating disorders

D.LuM.ArdayfioP.SparksJ.et al

Many commercial plans now cover GLP-1 drugs for obesity, but prior authorization requirements, step-therapy mandates, and cost-sharing can still create significant barriers

Propionyl-L-carnitine increases cellular carnitine content, thereby allowing free fatty acid transport into the mitochondria

Thyroiditis (inflammation of the thyroid), which may occur in pregnancy or in the context of some autoimmune conditions, is another uncommon cause of hyperthyroidism

Alissa: For employer groups who are considering covering weight loss, its important to note that while it can initially increase drug spend, it can have a lot of favorable impacts down the line to reduce medical spend